Today: 19 June 2026
Browse Category

NASDAQ:KARD 19 June 2026

Kardigan completed its first trading session on Nasdaq at $22 per share, which is a 37.5% increase from its IPO price of $16. The company raised $400 million through an enlarged initial public offering. Kardigan is the fourth biotech company in 2026 to raise at least $400 million in an IPO, as reported by BioPharma Dive.

Stock Market Today

  • Investors Eye MSGS and MSGE Stocks After Knicks Win NBA Championship
    June 18, 2026, 9:11 PM EDT. The New York Knicks' first NBA championship in 53 years has sparked investor interest in Madison Square Garden Sports (MSGS) and Madison Square Garden Entertainment (MSGE). MSGS owns the Knicks and benefits directly from the title through increased franchise value, fan engagement, merchandise sales, and sponsorship appeal. The Knicks rank as the sixth most valuable sports franchise globally, valued at $9.75 billion. Conversely, MSGE owns iconic venues like Madison Square Garden but not the Knicks themselves. MSGE could see indirect gains from heightened venue prestige and increased event demand. Investors should note the companies' distinct asset bases before investing to capitalize on the championship's financial impacts.

Latest articles

Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Go toTop